RANDY BULLOCK: Open Payments
NPI 1528099231 · OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$236 in 12 payments from 7 companies in 2025. Trend: 2023 $25 · 2024 $182 · 2025 $236
Food & beverage: $236
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 3 | $67 |
| E.R. Squibb & Sons, L.L.C. | 3 | $64 |
| Teva Pharmaceuticals USA, Inc. | 2 | $30 |
| Indivior Inc. | 1 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: LYBALVI, COBENFY, UZEDY, SUBLOCADE, Jornay PM, INVEGA SUSTENNA, CAPLYTA.
Industry payments across UT — which companies pay providers there.
